Upregulation of tumor necrosis factor receptor-associated factor 6 correlated with synovitis severity in rheumatoid arthritis

Arthritis Research and Therapy

Volumn 14, Issue 3, 2012, Pages

  Zhu, Lang Jing ^a   Dai, Lie ^a   Zheng, Dong Hui ^a   Mo, Ying Qian ^a   Ou Yang, Xia ^a   Wei, Xiu Ning ^a   Shen, Jun ^a   Zhang, Bai Yu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD68 ANTIGEN; CD79A ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ADULT; AGED; ARTHROPATHY; ARTICLE; CELL DENSITY; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; JOINT BIOPSY; JOINT RADIOGRAPHY; MALE; ORTHOPEDIC ARTHROPATHY; OSTEOARTHRITIS; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVITIS; UPREGULATION; BIOSYNTHESIS; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MIDDLE AGED; SYNOVITIS; TNF RECEPTOR-ASSOCIATED FACTOR 6; UP-REGULATION; YOUNG ADULT;

EID: 84861754745     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3866     Document Type: Article

References (49)

1. Kamijo S, Nakajima A, Ikeda K, Aoki K, Ohya K, Akiba H, Yagita H, Okumura K. Amelioration of bone loss in collagen-induced arthritis by neutralizing anti-RANKL monoclonal antibody. Biochem Biophys Res Commun 2006, 347:124-132. 10.1016/j.bbrc.2006.06.098, 16815304.
2. Tak PP. Is early rheumatoid arthritis the same disease process as late rheumatoid arthritis?. Best Pract Res Clin Rheumatol 2001, 15:17-26. 10.1053/berh.2000.0123, 11358412.
3. Choy EHS, Panayi G. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Eng J Med 2001, 344:907-916.
4. Kirwan JR. Links between radiological change, disability, and pathology in rheumatoid arthritis. J Rheumatol 2001, 28:881-886.
5. Wang Q, Ma Y, Liu D, Zhang L, Wei W. The roles of B cells and their interactions with fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis. Int Arch Allergy Immunol 2011, 155:205-211. 10.1159/000321185, 21293141.
6. Karsdal MA, Woodworth T, Henriksen K, Maksymowych WP, Genant H, Vergnaud P, Christiansen C, Schubert T, Qvist P, Schett G, Platt A, Bay-Jensen AC. Biochemical markers of ongoing joint damage in rheumatoid arthritis - current and future applications, limitations and opportunities. Arthritis Res Ther 2011, 13:215. 10.1186/ar3280, 3132026, 21539724.
7. Mo YQ, Dai L, Zheng DH, Zhu LJ, Wei XN, Pessler F, Shen J, Zhang BY. Synovial Infiltration with CD79a-positive B cells, but not other B cell lineage markers, correlates with joint destruction in rheumatoid arthritis. J Rheumatol 2011, 38:2301-2308. 10.3899/jrheum.110615, 22002013.
8. Schett G, Hayer S, Zwerina J, Redlich K, Smolen JS. Mechanisms of disease: the link between RANKL and arthritic bone disease. Nat Clin Pract Rheumatol 2005, 1:47-54. 10.1038/ncprheum0036, 16932627.
9. Bromley M, Woolley DE. Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum 1984, 27:968-975. 10.1002/art.1780270902, 6236824.
10. Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 1998, 152:943-951. 1858257, 9546355.
11. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176. 10.1016/S0092-8674(00)81569-X, 9568710.
12. Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schlöndorff J, Tempst P, Choi Y, Blobel CP. Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 1999, 274:13613-13618. 10.1074/jbc.274.19.13613, 10224132.
13. Crotti TN, Smith MD, Weedon H, Ahern MJ, Findlay DM, Kraan M, Tak PP, Haynes DR. Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. Ann Rheum Dis 2002, 61:1047-1054. 10.1136/ard.61.12.1047, 1753975, 12429533.
14. Tolar J, Teitelbaum SL, Orchard PJ. Osteopetrosis. N Engl J Med 2004, 351:2839-2849. 10.1056/NEJMra040952, 15625335.
15. Naito A, Azuma S, Tanaka S, Miyazaki T, Takaki S, Takatsu K, Nakao K, Nakamura K, Katsuki M, Yamamoto T, Inoue J. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 1999, 4:353-362. 10.1046/j.1365-2443.1999.00265.x, 10421844.
16. Armstrong AP, Tometsko ME, Glaccum M, Sutherland CL, Cosman D, Dougall WC. A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function. J Biol Chem 2002, 277:44347-44356. 10.1074/jbc.M202009200, 12185073.
17. Wu H, Arron JR. TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. Bioessays 2003, 25:1096-1105. 10.1002/bies.10352, 14579250.
18. Li X, Qin J. Modulation of Toll-interleukin 1 receptor mediated signaling. J Mol Med 2005, 83:258-266. 10.1007/s00109-004-0622-4, 15662540.
19. Arranz A, Gutiérrez-Cañas I, Carrión M, Juarranz Y, Pablos JL, Martínez C, Gomariz RP. VIP reverses the expression profi{ligature}ling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fi{ligature}broblasts. Mol Immunol 2008, 45:3065-3073. 10.1016/j.molimm.2008.03.011, 18452992.
20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
21. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010, 62:2569-2581. 10.1002/art.27584, 20872595.
22. Pessler F, Ogdie A, Diaz-Torne C, Dai L, Einhorn E, Schumacher HR. Subintimal Ki-67 as a synovial biomarker of inflammatory arthropathies. Ann Rheum Dis 2008, 67:162-167. 10.1136/ard.2007.071670, 17613556.
23. Singh JA, Arayssi T, Duray P, Schumacher HR. Immunohistochemistry of normal human knee synovium: a quantitative study. Ann Rheum Dis 2004, 63:785-790. 10.1136/ard.2003.013383, 1755068, 15194572.
24. Gerlag D, Tak PP. Synovial biopsy. Best Pract Res Clin Rheumatol 2005, 19:387-400. 10.1016/j.berh.2005.01.005, 15939365.
25. Krenn V, Morawietz L, Burmester GR, Kinne RW, Mueller-Ladner U, Muller B, Haupl T. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 2006, 49:358-364. 10.1111/j.1365-2559.2006.02508.x, 16978198.
26. Slansky E, Li J, Häupl T, Morawietz L, Krenn V, Pessler F. Quantitative determination of the diagnostic accuracy of the synovitis score and its components. Histopathology 2010, 57:436-443. 10.1111/j.1365-2559.2010.03641.x, 20840673.
27. Bresnihan B, Cunnane G, Youssef P, Yanni G, Fitzgerald O, Mulherin D. Microscopic measurement of synovial membrane inflammation in rheumatoid arthritis: proposals for evaluation of tissue samples by quantitative analysis. Br J Rheumatol 1998, 37:636-642. 10.1093/rheumatology/37.6.636, 9667617.
28. Youssef PP, Smeets TJ, Bresnihan B, Cunnane G, Fitzgerald O, Breedveld F, Tak PP. Microscopic measurement of cellular infiltration in the rheumatoid arthritis synovial membrane: a comparison of semiquantitative and quantitative analysis. Br J Rheumatol 1998, 37:1003-1007. 10.1093/rheumatology/37.9.1003, 9783767.
29. Tak PP, Smeets TJ, Daha MR, Kluin PM, Meijers KA, Brand R, Meinders AE, Breedveld FC. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum 1997, 40:217-225. 10.1002/art.1780400206, 9041933.
30. Haynes D, Crotti T, Weedon H, Slavotinek J, Au V, Coleman M, Roberts-Thomson PJ, Ahern M, Smith MD. Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease-modifying antirheumatic drug treatment and correlation with radiologic outcome. Arthritis Rheum 2008, 59:911-920. 10.1002/art.23818, 18576301.
31. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48. 10.1002/art.1780380107, 7818570.
32. Koh ET, Seow A, Pong LY, Koh WH, Chan L, Howe HS, Lim TH, Low CK. Cross cultural adaptation and validation of the Chinese Health Assessment Questionnaire for use in rheumatoid arthritis. J Rheumatol 1998, 25:1705-1708.
33. Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, Decker JL, Genant HK, Gofton JP, Goodman N, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?. Arthritis Rheum 1985, 28:1326-1335. 10.1002/art.1780281203, 4084327.
34. van der Heijde DM. How to read radiographs according to the Sharp/van der Heijde method. J Rheumotal 2000, 27:261-263.
35. Smeets TJ, Barg EC, Kraan MC, Smith MD, Breedveld FC, Tak PP. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis. Ann Rheum Dis 2003, 62:635-638. 10.1136/ard.62.7.635, 1754593, 12810425.
36. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361. 10.1038/nature01661, 12748655.
37. Kay J, Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 2004, 43(Suppl 3):iii2-iii9.
38. Proudman SM, Cleland LG, Mayrhofer G. Effects of tumor necrosis factor-α, interleukin-1β, and activated peripheral blood mononuclear cells on the expression of adhesion molecules and recruitment of leukocytes in rheumatoid synovial xenografts in SCID mice. J Rheumatol 1999, 26:1877-1889.
39. Chung JY, Park YC, Ye H, Wu H. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci 2002, 115:679-688.
40. O'Neill LA. Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?. Nat Clin Pract Rheumatol 2008, 4:319-327. 10.1038/ncprheum0802, 18446139.
41. Tamaki Y, Takakubo Y, Hirayama T, Konttinen YT, Goodman SB, Yamakawa M, Takagi M. Expression of Toll-like receptors and their signaling pathways in rheumatoid synovitis. J Rheumatol 2011, 38:810-820. 10.3899/jrheum.100732, 21324962.
42. Huang QQ, Pope RM. The role of toll-like receptors in rheumatoid arthritis. Curr Rheumatol Rep 2009, 11:357-364. 10.1007/s11926-009-0051-z, 2913446, 19772831.
43. Tsubaki T, Takegawa S, Hanamoto H, Arita N, Kamogawa J, Yamamoto H, Takubo N, Nakata S, Yamada K, Yamamoto S, Yoshie O, Nose M. Accumulation of plasma cells expressing CXCR3 in the synovial subintima regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts. Clin Exp Immunol 2005, 141:363-371. 10.1111/j.1365-2249.2005.02850.x, 1809426, 15996201.
44. Ahonen C, Manning E, Erickson LD, O'Connor B, Lind EF, Pullen SS, Kehry MR, Noelle RJ. The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells. Nat Immunol 2002, 3:451-456. 10.1038/ni792, 2834483, 11967542.
45. Fujikawa Y, Sabokbar A, Neale S, Athanasou NA. Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis. Ann Rheum Dis 1996, 55:816-822. 10.1136/ard.55.11.816, 1010317, 8976638.
46. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999, 402:304-309. 10.1038/46303, 10580503.
47. Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 2000, 43:259-269. 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W, 10693864.
48. Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, van der Heijde D, Zhou L, Tsuji W, Newmark R. Denosumab Rheumatoid Arthritis Study Group: Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum 2008, 58:1299-1309. 10.1002/art.23417, 18438830.
49. Shiozawa S, Tsumiyama K, Yoshida K, Hashiramoto A. Pathogenesis of joint destruction in rheumatoid arthritis. Arch Immunol Ther Exp (Warsz) 2011, 59:89-95.